Board Member
Cue Biopharma, Inc. (CUE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Dr. Shao-Lee Lin is recorded as CEO and Board Member at Cue Biopharma, Inc. (CUE). Cue Biopharma, Inc. reported in an 8-K filed May 1, 2026 that Dr. Shao-Lee Lin was appointed member of the Board, effective April 30, 2026. Cue Biopharma, Inc. reported in an 8-K filed May 1, 2026 that Dr. Shao-Lee Lin was appointed President and Chief Executive Officer, effective April 30, 2026. Dr. Shao-Lee Lin has spoken on 1 investor event across 1 company, most recently for Cue Biopharma, Inc. on September 21, 2026.
“On April 27, 2026, the Board appointed Dr. Shao-Lee Lin as the Company’s President and Chief Executive Officer and as a member of the Board, effective as of her commencement of employment with the Company, which began on April 30, 2026 (the “Effective Date”).”
“On April 27, 2026, the Board appointed Dr. Shao-Lee Lin as the Company’s President and Chief Executive Officer and as a member of the Board, effective as of her commencement of employment with the Company, which began on April 30, 2026 (the “Effective Date”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2026-04-30–present
2026-04-30–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2026-04-30–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
